• Home
  • Documentation
en
Scientific article
Letter
Open access
English

Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis

ContributorsFraga, Montserrat; Moradpour, Darius; Artru, Florent; Romailler, Elodie; Tschopp, Jonathan; Schneider, Antoine; Chtioui, Haithem; Neerman Arbez, Margueriteorcid; Casini, Alessandroorcid; Alberio, Lorenzo; Sempoux, Christine
Published inJournal of Hepatology, vol. 150, w20301
Publication date2020
Abstract

Many centres have noticed a high number of venous thromboembolism (VTE) events among critically ill inpatients with COVID-19 pneumonia. The aims of this study were (1) to summarise the reported risk of VTE associated with COVID-19 infections and (2) to summarise guidance documents on thromboprophylaxis in COVID-19 patients, in a systematic review.

eng
Keywords
  • Anticoagulants/therapeutic use
  • Betacoronavirus
  • Coronavirus Infections/epidemiology
  • Fondaparinux/therapeutic use
  • Heparin/therapeutic use
  • Heparin
  • Low-Molecular-Weight/therapeutic use
  • Humans
  • Pandemics
  • Pneumonia
  • Viral/epidemiology
  • Practice Guidelines as Topic
  • Pulmonary Embolism/epidemiology/prevention & control
  • Risk
  • Venous Thromboembolism/epidemiology/prevention & control
  • Venous Thrombosis/epidemiology/prevention & control
Affiliation
Research group
Citation (ISO format)
FRAGA, Montserrat et al. Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis. In: Journal of Hepatology, 2020, vol. 150, p. w20301. doi: 10.1016/j.jhep.2020.06.021
Main files (1)
Article (Accepted version)
accessLevelPublic CC BY-NC-ND
Identifiers
ISSN of the journal0168-8278
345views
68downloads

Technical informations

Creation07/29/2020 6:13:00 PM
First validation07/29/2020 6:13:00 PM
Update time05/03/2024 5:21:30 PM
Status update05/03/2024 5:21:30 PM
Last indexation05/03/2024 5:21:34 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack